Senores Pharmaceuticals Limited has informed the Exchange regarding intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Regulatory & Legal View source PDF Explain this filing

SENORES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹825.00

prior close

₹827.65

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.1%-0.2% vs market

Pharmaceuticals peers, median of 156sector-0.2%-0.0% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.7

15m

-0.1

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.2-0.1-0.2-0.2-0.0

Next day

-0.3+1.3-1.6+0.6-0.8

+0.1+1.6-1.4+0.8-0.7

+4.6+2.5+2.1+1.7+2.9

+2.4+2.8-0.4+1.3+1.1

+2.2+2.1+0.1+1.5+0.7

-0.4+0.1-0.5+0.4-0.8

15d

+1.7-7.2+8.8-6.1+7.8

-4.5-4.4-0.1-5.8+1.2

-6.8-6.4-0.4-7.5+0.7

-7.9-15.1+7.2-17.1+9.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Senores Pharmaceuticals has received a demand order dated December 26, 2025 from the Office of Deputy/Assistant Commissioner of Central GST & Central Excise, Ahmedabad-North. The order confirms a tax demand of Rs. 24.84 lakh along with an equivalent penalty of Rs. 24.84 lakh, totaling approximately Rs. 49.69 lakh. The alleged issues are non-reversal of excess Input Tax Credit and non-payment of IGST. The company plans to file an appeal before the GST Commissioner (Appeals). Management has stated that there is no material impact expected on the company's financials, operations, or other activities.

Likely market impact

The financial impact is relatively minor (~Rs. 49.69 lakh combined demand and penalty) and the company is contesting it through appeal. Shareholders are unlikely to see a significant effect on the stock, though it remains a pending tax dispute worth monitoring for the final outcome.